Texas Capital starts Herbalife at Buy after 'transformational period'
Upside potential supported by a new Buy rating from UBS and a substantial target above current price.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential supported by a new Buy rating from UBS and a substantial target above current price.
What happened, with direct paths to the underlying reporting
UBS initiates Herbalife (HLF) at Buy with a target of $21. Current price is $11.83; priceChangeSinceSignal: +2.66.
Target: $21
Posted price: $11.83
Analyst firm: UBS
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.